Verastem, Inc. Payments for Restructuring
Verastem, Inc. (VSTM) reported Payments for Restructuring of $1.03 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2022-03-28
- Verastem, Inc. payments for restructuring for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Verastem, Inc. payments for restructuring for the quarter ending 2021-09-30 was $13.00K, a 97.93% decline year-over-year.
- Verastem, Inc. payments for restructuring for the quarter ending 2021-06-30 was $107.00K, a 89.96% decline year-over-year.
- Verastem, Inc. payments for restructuring for the quarter ending 2021-03-31 was $907.00K, a 55.31% increase year-over-year.
- Verastem, Inc. payments for restructuring for fiscal 2021 was $1.03M, a 75.75% decline from fiscal 2020.
- Verastem, Inc. payments for restructuring for fiscal 2020 was $4.24M.
- Verastem, Inc. payments for restructuring for fiscal 2016 was $713.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $13.00K derived: sum of 2 quarters · filed 2022-03-28 | $120.00K derived: sum of 3 quarters · filed 2022-03-28 | $1.03M 10-K · filed 2022-03-28 |
| 2021-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $120.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.03M 10-Q · filed 2021-11-04 | $2.98M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $1.01M 10-Q · filed 2021-08-02 | $2.97M derived: sum of 3 quarters · filed 2021-08-02 | $3.60M derived: sum of 4 quarters · filed 2021-08-02 |
| 2021-03-31 | $907.00K 10-Q · filed 2021-05-11 | $2.86M derived: sum of 2 quarters · filed 2021-05-11 | $3.49M derived: sum of 3 quarters · filed 2021-05-11 | $4.56M derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $2.58M derived: sum of 2 quarters · filed 2021-03-18 | $3.65M derived: sum of 3 quarters · filed 2021-03-18 | $4.24M 10-K · filed 2021-03-18 |
| 2020-09-30 | $629.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.70M derived: sum of 2 quarters · filed 2020-11-09 | $2.28M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.65M 10-Q · filed 2020-08-10 | ||
| 2020-03-31 | $584.00K 10-Q · filed 2020-05-07 | |||
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $78.00K 10-Q · filed 2017-08-08 | $192.00K 10-Q · filed 2017-05-10 | $713.00K 10-K · filed 2017-03-23 |
| 2016-09-30 | $78.00K 10-Q · filed 2017-11-07 | $192.00K derived: sum of 2 quarters · filed 2017-11-07 | $713.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $114.00K 10-Q · filed 2017-08-08 | $635.00K 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $521.00K 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | $349.00K 10-Q · filed 2017-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |